The Global Network for Neglected Tropical Diseases’ “End The Neglect” blog highlights an event that took place in Paris on Wednesday where global leaders convened to discuss progress made in NTD efforts. The event “coincided with the release of a new report highlighting gains over the past two years … [and] signals the fact that controlling and eliminating NTDs is embraced by a global community of national leaders, policy makers, and donors. In addition, there is broad recognition that addressing NTDs is a crucial component of eliminating poverty and achieving development goals” (Gordon, 4/2). In The Lancet’s “Global Health Blog,” Julien Potet of Médecins Sans Frontières “examine[s] the challenges for access to medicines for three other high-burden neglected tropical diseases: human African trypanosomiasis, visceral leishmaniasis, and snakebites” and asserts that “[t]he stakeholders of the London Declaration need to think beyond donations by large pharmaceutical companies for a limited range of diseases and pursue new types of market-shaping partnerships with the pharmaceutical sector, including with smaller entities and companies from emerging economies” (4/1).